92828-74-5Relevant academic research and scientific papers
(+/-)-cis-2-Acetoxycyclobutyltrimethylammonium Iodide: A Semirigid Analogue of Acetylcholine
Cannon, Joseph G.,Crockatt, Dale M.,Long, John Paul,Maixner, William
, p. 1091 - 1094 (1982)
The title compound was prepared to complete a series of small ring (cyclopropane, cyclobutane) cis/trans 1,2-disubstituted semirigid congeners of acetylcholine.A multistep synthetic sequence, beginning with cis-cyclobutane-1,2-dicarboxylic anhydride, permitted unequivocal preparation of the (+/-)-cis target compound 4.The geometry of 4 was confirmed by comparison with an authentic sample of the (+/-)-trans isomer.The cis and trans isomers were equipotent as muscarinic agonists, but they were much weaker than acetyl-β-methylcholine.
Stereoselective chemoenzymatic synthesis of the four stereoisomers of L-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3
Faure, Sophie,Jensen, Anders A.,Maurat, Vincent,Gu, Xin,Sagot, Emmanuelle,Aitken, David J.,Bolte, Jean,Gefflaut, Thierry,Bunch, Lennart
, p. 6532 - 6538 (2007/10/03)
The four stereoisomers of L-2-(2-carboxycyclobutyl)glycine, L-CBG-I, L-CBG-II, L-CBG-III, and L-CBG-IV, were synthesized in good yield and high enantiomeric excess, from the corresponding cis and trans-2- oxalylcyclobutanecarboxylic acids 5 and 6 using the enzymes aspartate aminotransferase (AAT) and branched chain aminotransferase (BCAT) from Escherichia coli. The four stereoisomeric compounds were evaluated as potential ligands for the human excitatory amino acid transporters, subtypes 1, 2, and 3 (EAAT1, EAAT2, and EAAT3) in the FLIPR membrane potential assay. While the one trans-stereoisomer, L-CBG-I, displayed weak substrate activity at all three transporters, EAAT1-3, we found a particular pharmacological profile for the other trans-stereoisomer, L-CBG-II, which displayed EAAT1 substrate activity and inhibitory activity at EAAT2 and EAAT3. Whereas L-CBG-III was found to be a weak inhibitor at all three EAAT subtypes, the other cis-stereoisomer L-CBG-IV was a moderately potent inhibitor with 20-30-fold preference for EAAT2/3 over EAAT1.
